Centre Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Centre Asset Management's GILD Position: Q2 2023 in Review
Centre Asset Management sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 101,385 shares — an estimated $8.41M sold.
Centre Asset Management first reported a position in GILD in Q2 2013 and held it in 20 quarters. The position peaked at $21.4M in Q2 2015. 1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.
- Centre Asset Management reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
- Centre Asset Management sold 101,385 Gilead Sciences shares in Q2 2023, an estimated $8.41M.
- Centre Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 20 quarters.
- Centre Asset Management's Gilead Sciences position peaked at $21.4M in Q2 2015.
- 1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.
Based on Centre Asset Management's 13F filing for Q2 2023, filed 6 Jul 2023.